Social Cognitive Role of Schizophrenia Candidate Gene GABRB2 by Tsang, S.Y. et al.
Social Cognitive Role of Schizophrenia Candidate Gene
GABRB2
Shui Ying Tsang1, Songfa Zhong2,3, Lingling Mei1, Jianhuan Chen1, Siu-Kin Ng1, Frank W. Pun1,4,
Cunyou Zhao1, Bingyi Jing4,5, Robin Chark6, Jianhua Guo7, Yunlong Tan8, Lijun Li9, Chuanyue Wang9,
Soo Hong Chew2,3, Hong Xue1,4,10*
1Division of Life Science and Applied Genomics Laboratory, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China, 2Department of
Economics, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China, 3Department of Economics, National University of Singapore,
Singapore, Rep. of Singapore, 4Center for Statistical Science, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China, 5Department of
Mathematics, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China, 6Department of Marketing, National University of Singapore,
Singapore, Rep. of Singapore, 7 School of Mathematics and Statistics, Northeast Normal University, Changchun, China, 8 Beijing Huilongguan Hospital, Beijing, China,
9 Beijing Anding Hospital, Capital Medical University, Beijing, China, 10 State Key Laboratory of Molecular Neuroscience, Hong Kong University of Science and Technology,
Clear Water Bay, Hong Kong, China
Abstract
The occurrence of positive selection in schizophrenia-associated GABRB2 suggests a broader impact of the gene product on
population fitness. The present study considered the possibility of cognition-related GABRB2 involvement by examining the
association of GABRB2 with psychosis and altruism, respectively representing psychiatric and psychological facets of social
cognition. Four single nucleotide polymorphisms (SNPs) were genotyped for quantitative trait analyses and population-
based association studies. Psychosis was measured by either the Positive and Negative Syndrome Scale (PANSS) or
antipsychotics dosage, and altruism was based on a self-report altruism scale. The minor alleles of SNPs rs6556547,
rs1816071 and rs187269 in GABRB2 were correlated with high PANSS score for positive symptoms in a Han Chinese
schizophrenic cohort, whereas those of rs1816071 and rs1816072 were associated with high antipsychotics dosage in a US
Caucasian schizophrenic cohort. Moreover, strongly significant GABRB2-disease associations were found among
schizophrenics with severe psychosis based on high PANSS positive score, but no significant association was observed
for schizophrenics with only mild psychosis. Interestingly, in addition to association with psychosis in schizophrenics,
rs187269 was also associated with altruism in healthy Han Chinese. Furthermore, parallel to correlation with severe
psychosis, its minor allele was correlated with high altruism scores. These findings revealed that GABRB2 is associated with
psychosis, the core symptom and an endophenotype of schizophrenia. Importantly, the association was found across the
breadth of the psychiatric (psychosis) to psychological (altruism) spectrum of social cognition suggesting GABRB2
involvement in human cognition.
Citation: Tsang SY, Zhong S, Mei L, Chen J, Ng S-K, et al. (2013) Social Cognitive Role of Schizophrenia Candidate Gene GABRB2. PLoS ONE 8(4): e62322.
doi:10.1371/journal.pone.0062322
Editor: Chunyu Liu, University of Illinois at Chicago, United States of America
Received August 30, 2012; Accepted March 20, 2013; Published April 24, 2013
Copyright:  2013 Tsang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Fok Ying Tung Group, the Research Grants Council of Hong Kong (RGC grant no. 662811) and the National Basic
Research Program of China (Project no. 2012CB517902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hxue@ust.hk
Introduction
Schizophrenia (SCZ) is a common, multi-factor psychiatric
disorder characterized by a strong genetic component, with
heritability of around 0.81 [1]. SCZ is clinically heterogeneous and
this may reflect underlying genetic heterogeneity. Multiple
susceptibility genes for SCZ include DISC [2], COMT [3], NRG1
[4] and GABRB2 encoding the GABAA receptor b2 subunit gene
for which we reported SCZ associations for single nucleotide
polymorphisms (SNPs) and haplotypes in Introns 8 and 9 in
a Chinese population-based study [5]. This SCZ-GABRB2
association was subsequently validated by us using German and
Japanese sample cohorts [6,7] as well as by other researchers using
additional samples from Chinese, German and Portuguese cohorts
[8,9]. Contribution of GABRB2 to SCZ etiology was further
supported by the differential expression of different splicing
variants of the gene in SCZ patients relative to control subjects
[10,11]. Recently, evidence for imprinting of GABRB2 was
revealed [12], supporting the involvement of genomic imprinting
in the development of SCZ [13]. That the disorder persists in the
face of its reproductive disadvantage poses an apparent evolu-
tionary paradox [14], and the findings of co-occurrence of
recombination and positive selection in this region of GABRB2
[15,16] has shed some insight into potential genetic mechanisms
underlying the phenomenon. Moreover, the positive selection in
GABRB2 suggests that the GABAA receptor b2 subunit may exert
a broader impact beyond SCZ morbidity.
Psychosis (referring to psychotic symptoms and not to psychotic
disorders) features prominently in many neuropsychiatric diseases
including SCZ, bipolar disorder (BPD) and neurodegenerative
disorders like Alzheimer’s disease. It has been associated also with
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impaired cognitive function [17] as well as social cognition
[18,19]. In biological terms, over-activity of the mesolimbic
dopamine pathway has been suggested as a contributor to the
positive symptoms of psychosis including delusions and hallucina-
tions; a number of genes in the dopamine pathway including
COMT [20] and DTNBP1 [21] showed association with risk of
psychosis. Other SCZ-associated genes were reported to be
involved in psychotic susceptibility in different psychiatric dis-
orders [22,23,24,25], which included GABRB2 association with
psychotic risk in BPD [26], suggesting that genetic modulation
operates more on the psychosis endophenotype level rather than
being localized to any particular psychiatric diagnosis. In keeping
with this, a number of candidate susceptibility genes for psychiatric
disorders were found to be involved in normal cognition-related
behavior [27,28,29,30,31], suggesting that these genes could
regulate both typical and impaired cognitive processes. Indeed,
for prosocial behavior such as empathy, cooperativeness and
altruism, where social cognition constitutes an essential compo-
nent, heritability estimates of about 50% were obtained [32], with
possible involvement of the dopaminergic system [33]. Since
intricate interactions occur between the dopaminergic and
GABAergic systems, genes in the GABA pathway could well
participate in such cognition-related phenotypes as psychosis and
prosocial behavior.
In the present study, the possible correlation between psychosis
and SNPs in the SCZ-associated GABRB2 gene was examined with
respect to the severity of psychosis assessed on the basis of Positive
and Negative Syndrome Scale (PANSS) [34] and antipsychotics
treatment dosages administered to SCZ patients. In parallel, the
possible association of these SNPs with prosocial altruistic behavior
was evaluated in healthy subjects to explore any genetic overlap
between psychosis and altruism, respectively representing psychi-




Written consent was obtained from all subjects prior to the
study. Approval for the study was obtained from the ethical
committees of Beijing Anding Hospital, Beijing Huilongguan
Hospital and Beijing Normal University.
DNA Samples
For the disease-association studies, Han Chinese patients were
recruited from the psychiatric wards of Beijing Anding Hospital
and Beijing Huilongguan Hospital, and control subjects were
region-matched Han Chinese. The patients were diagnosed
according to the Diagnostic and Statistical Manual of Mental
Disorders (DSM)-IV criteria [35] and additionally assessed for
PANSS scores. The subjects consisted of 115 schizophrenia
patients (70 males, 45 females) and 117 controls (54 males, 63
females). For genotype-altruism correlations, 209 Han Chinese
students (96 males, 113 females, age 22.562.4) were recruited
from Beijing Normal University. All subjects were unrelated, and
genomic DNA was extracted from blood samples. For anti-
psychotics correlation studies, US Caucasian DNA and RNA
samples from the Stanley Array Collection were extracted from
postmortem dorsolateral prefrontal cortex (DLPFC) gray matter
(Brodmann’s area 46) of 35 schizophrenics (26 males, 9 females)
and 35 control subjects (26 males, 9 females). All samples were
successfully extracted and used in further analysis.
To sequence the 3,551-bp segment flanked by SNPs rs6556547
and rs187269 in GABRB2, two genomic DNA regions were PCR-
amplified to serve as first PCR templates for subsequent nested-
PCR. The nested-PCR approach was adopted to increase
amplification specificity. Nested-PCR and SNP genotyping by
resequencing of the nested PCR products were carried out as
described [15]. Primers for the PCR and sequencing reactions are
given in Table S1. The genotyping completion rates were over
99% for the tested SNPs.
Altruism Assessment
The self-report altruism scale [36] in the form of a questionnaire
was used to assess altruistic attitudes, where altruistic behavior was
identified by frequency of actions taken during the past year in 17
Figure 1. Post-hoc analyses of genetic effects on PANSS scores,
antipsychotic dosage and altruism scores. PANSS positive scores
(PANSS Score) of Chinese male schizophrenics (Part A), average
antipsychotics dosage, in mg fluphenazine equivalents per day, of US
schizophrenics (Part B) and altruism scores of healthy Chinese subjects
(Parts C) are shown. The homozygous major genotype is shown by
white column, heterozygous genotype by lighter colored column, and
homozygous minor genotype by darker colored column, as mean 6
standard error. Symbol *denotes significant difference (p,0.05 based
on Mann-Whitney U test) between the two line-connected genotypes.
doi:10.1371/journal.pone.0062322.g001
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situations such as giving directions, helping people in need, and
lending money on a scale of 1 (never) to 5 (very often).
Statistical Analysis
Exact test of Hardy-Weinberg Equilibrium (HWE) was
performed on SNPs in the control samples using GENEPOP 4.0
as described [6], and linkage disequilibrium (LD) was calculated
using the DnaSP v5 program [37]. Pairwise haplotypes were
inferred from the SNP genotypes of individual subjects using
PHASE version 2.1 [38], and haplotypes with less than 1%
frequencies were not included in the calculations. Genetic
correlations with antipsychotics dosage, PANSS score, and
altruistic tendency were analyzed using the linear-by-linear
association test, Mann-Whitney U test and linear regression tests
in the SPSS v11.5 package (SPSS, Chicago, IL, USA). Power
estimates were performed using the PS program, version 3.0 [39].
Disease association was analyzed using the likelihood ratio statistic
(LRS) test in UNPHASED program version 3.1.3 [40]. Permu-
tation and resampling tests were chosen as validation tests. A
global permutation test from UNPHASED employing 10,000
permutations for each SNP or haplotype with a p-value from the
LRS test of less than 0.05 was performed. For resampling tests,
1,000 resampled datasets for each trait were generated by random
extraction with replacement. Linear regression was performed for
each SNP in each resampled dataset and the number of datasets
per 1,000 sets showing significant correlation (p,0.05) were
recorded. GABRB2 isoforms expression and effects of sex on
antipsychotics dosage, PANSS score, and altruism score were also
analyzed using the Mann-Whitney U test; effects of age on the
various traits were analyzed using Pearson’s correlation test.
Results
The four SCZ-associated SNPs rs6556547 (S1), rs1816071 (S3),
rs1816072 (S5) and rs187269 (S29) used previously in our analysis
of positive selection [15], sequentially contained in a 3,551-bp
fragment in GABRB2, were analyzed in the present study. The
SNP code numbers in parentheses are adopted from our previous
designations [12,15]. No deviation from HWE (p.0.05) was
detected for any of these SNPs in either the Chinese or US
cohorts. Only the SNPs S3 and S5 in the US cohort but not in the
Chinese cohort were completely linked, based on pairwise LD
r2 = 0.94 for the US samples (Figure S1). Moreover, neither age
nor sex exerted significant effects on PANSS score, antipsychotics
dosage or altruism score.
GABRB2 Association with PANSS Scores
Although the PANSS scores for positive symptoms (hereafter,
unless stated otherwise, PANSS scores will refer to PANSS scores
for positive symptoms) such as hallucinations and delusions for the
full cohort of 70 male and 45 female Han Chinese SCZ patients
were not significantly correlated with any GABRB2 SNP genotype,
the PANSS scores of the 70 male patients were significantly
correlated with S1, S3 and S29 with p=0.010, 0.010 and 0.041
respectively (Table 1), in each case with a positive correlation
between the number of minor alleles and PANSS scores. The S29
correlation result did not pass the Bonferroni multiple test
correction. In post-hoc analysis, higher PANSS scores were
correlated with the S1 and S3 homozygous minor (p=0.019 and
0.041, respectively) and the S1, S3 and S29 heterozygous
(p=0.043, 0.017 and 0.039, respectively; Figure 1A) genotypes
compared to the corresponding homozygous major genotypes; and
in the resampling tests, significant correlations (p,0.05) were
observed between PANSS score and the S1, S3 and S29 genotypes
for 737, 760 and 559 datasets, respectively, out of 1,000 resampled
datasets. SNPs S1, S3 and S29 also showed significant correlation
at the allele level (p,0.05), and four of the six inferred two-SNP
haplotypes showed significant (p,0.05) correlations with PANSS
score (Table S2). Moreover, the PANSS scores showed a pro-
pensity to increase linearly with increasing number of minor alleles
Figure 2. Quantitative correlation of minor allele load with
PANSS scores, antipsychotics dosage and altruism scores. The
bubble plot shows linear correlation between (A) PANSS positive score,
(B) antipsychotics dosage and (C) altruism score and the number of
minor alleles present at the four SNP locations (R2 = 0.51, 0.56 and 0.69,
respectively, based on average score or dosage; p= 0.005, 0.022 and
0.033, respectively, based on linear regression analysis of original
dataset). The bubbles represent average score or dosage, and their size
represents the number of subjects.
doi:10.1371/journal.pone.0062322.g002
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present across the four SNP positions (Figure 2A; p=0.005).
Notably, for the full cohort as well as the two gender subgroups,
none of the SNPs was significantly correlated (p.0.05) with the
PANSS scores for negative symptoms such as emotional
withdrawal or general symptoms such as anxiety, or with the
total PANSS scores for all symptoms.
The full cohort of 115 Han Chinese SCZ patients were
separated into two groups based on their PANSS scores using the
K-Means clustering function (Figure 3A). The full patient cohort,
and the thus-separated ‘high PANSS score’ and ‘low PANSS
score’ subgroups were each compared to the 117 healthy control
subjects by means of the LRS test in UNPHASED. SNPs S1, S3
and S29 were significantly associated with SCZ in the full patient
cohort in agreement with previous reports on association of
GABRB2 SNPs with SCZ in Han Chinese [5,41]. Interestingly,
many of the association p-values of these SNPs with SCZ in the
high PANSS score subgroup were drastically decreased to less than
10% of the full cohort p-values; e.g., the full cohort p-values for
SNP S1 of 0.005 and 0.014 for allele and genotype associations,
respectively, were decreased to 0.0004 and 0.001 in the high
PANSS score subgroup (Table 2). In contrast, there was no
significant association of SCZ with any of the SNPs in the low
PANSS score subgroup. The results reflected considerable
increases in the frequencies of minor alleles and minor-allele-
containing genotypes in the high PANSS score subgroup relative
to control (Figure 4; Table S3). Such increases were negligible in
the low PANSS score subgroup. Moreover, for all six pairwise
haplotypes examined in Table 3, the p-values reflected highest
significance in the high PANSS score subgroup, lower significance
in the full cohort, and no significance (p.0.05) in the low PANSS
score subgroup.
GABRB2 Association with Antipsychotics Dosage
The daily average antipsychotics dosages administered to US
SCZ patients over their duration of illness were derived according
to the equation:
average dosage~
life time fluphenazine equivalents in mg
duration of illness in days
When SNPs S3, S5 and S29 were correlated with the daily
average antipsychotics dosage (S1 was not included in the analysis
on account of its low minor allele sample size), significant
correlation was observed in the case of S5 with p=0.031
(Table 1). The result did not pass the Bonferroni multiple test
correction. Nevertheless, in post-hoc analysis, the S3 and S5
homozygous minor genotypes were associated with significantly
higher average dosages than the homozygous major genotypes
(p=0.037 and 0.010, respectively; Figure 1B); and in the
resampling test, 634 out of 1,000 resampled datasets were
significant (p,0.05) for S5 genotype correlation with antipsycho-
Table 1. Quantitative trait analyses of PANSS score, antipsychotics dosage and altruism score.
PANSS Antipsychotics dosage Altruism
Male+Female Male only Male+Female Male only Male+Female Male only
















S1 G/T G 0.165 0.079 0.308 0.010 – – – – 0.105 0.131 0.140 0.174
S3 A/G A 0.130 0.166 0.312 0.010 0.273 0.111 0.260 0.194 0.089 0.209 0.111 0.281
S5 T/C T 0.024 0.801 0.177 0.141 0.370 0.031 0.260 0.194 0.052 0.451 0.118 0.248
S29 T/C T 0.133 0.156 0.246 0.041 0.190 0.268 0.136 0.497 0.159 0.023 0.170 0.099
Genetic effects on PANSS positive scores (PANSS Score) of Chinese schizophrenics; average antipsychotics dosage, in mg fluphenazine equivalents per day, of US
schizophrenics; and altruism scores of healthy Chinese subjects are shown. The power estimates for the three cohorts were 0.6, 0.4 and 0.8, respectively. The effect sizes
were represented by Pearson’s r values, and the p-values were obtained using the linear-by-linear association test in SPSS for additive effect testing. Significant p values
(p,0.05) are shown in bold font.
doi:10.1371/journal.pone.0062322.t001
Table 2. GABRB2 association in PANSS score-based SCZ subgroups.
All (n =115) High score (n =56) Low score (n=59)
Allele Genotype Allele Genotype Allele Genotype
SNP p OR 95% CI p p OR 95% CI p p OR 95% CI p
S1 0.005 2.04 1.24–3.38 0.014 461024 2.82 1.59–4.99 0.001 0.288 1.41 0.75–2.65 0.548
S3 0.014 1.66 1.10–2.49 0.042 0.001 2.25 1.39–3.64 0.006 0.466 1.21 0.73–2.00 0.437
S5 0.293 1.22 0.84–1.78 0.177 0.080 1.51 0.95–2.38 0.114 0.988 1.00 0.63–1.58 0.430
S29 0.010 1.82 1.15–2.88 0.044 0.001 2.40 1.41–4.08 0.008 0.311 1.35 0.76–2.38 0.613
The Beijing SCZ cohort (‘All’) was partitioned into ‘High score’ and ‘Low score’ subgroups by applying the K-Means clustering function to the PANSS scores for positive
symptoms. The p-values were obtained from case-control association analysis using the likelihood ratio test. Significant p values (p,0.05) that passed the global
permutation test are shown in bold font. The odds ratio (OR) and its 95% confidence level (CI) were based on allele frequencies.
doi:10.1371/journal.pone.0062322.t002
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tics dosage. SNP S5 also showed significant correlation at the allele
level (p,0.05), and the inferred pairwise haplotypes S3–S5 and
S5–S29 were significantly correlated with antipsychotics dosage
(Table S2). Moreover, the average dosage increased linearly with
increasing number of minor alleles present across the three SNP
positions (Figure 2B; p=0.022).
Based on the clinical recommendation of 1–5 mg/day fluphen-
azine as a standard maintenance dose for SCZ and other psychotic
disorders [42], patients could be separated into a ‘high-dosage’
.5 mg and a ‘low (or standard)-dosage’ # 5 mg subgroups
(Figure 3B). Of note, there were no subjects with S3, S5 or S29
homozygous minor genotype in the low dosage subgroup.
Although there was no significant association of S3, S5 or S29
with SCZ for the full US cohort or low antipsychotics dosage
subgroup, for the high dosage subgroup significant associations of
S5 (Table 4; p=0.034) as well as S5–S29 haplotype (Table 3;
p=0.034) with SCZ were observed, as well as an evident trend
that the p-values of association were lower in the high dosage
subgroup than in the low dosage subgroup. Moreover, the S3 and
S5 minor allele and homozygous minor frequencies were
considerably elevated in the high dosage subgroup over the
controls (Figure 5; Table S3). These results were entirely in
agreement with the analysis based on PANSS scores in the
Chinese cohort (Tables 2 and 3).
Previously, the US samples showed correlations between SCZ
and expression of GABRB2 isoforms, including the two long
recognized short b2S and long b2L isoforms [10] as well as the two
novel isoforms b2S1 and b2S2 [11]. Figure 6 shows that, upon
partition of the US SCZ samples into the high and low
antipsychotics dosage subgroups, significant differences in
GABRB2 expression with respect to all four isoforms were observed
between healthy controls and the high dosage subgroup, but not
between controls and the low dosage subgroup.
GABRB2 Association with Altruism
When the altruistic behavior of normal subjects was assessed
based on the self-report altruism scale [36], significant association
was observed between altruistic behavior and S29 (p=0.023),
based on an additive effect test with a positive correlation between
the number of minor alleles and altruism scores (Table 1). The
result did not pass the Bonferroni multiple test correction.
Nevertheless, in post-hoc analysis, subjects with the homozygous
minor genotype of S29 were significantly more altruistic than
subjects with the homozygous major genotype (p=0.043;
Figure 1C), and in the resampling test, 619 out of 1,000 resampled
datasets showed significant correlation (p,0.05) between S29
genotype and altruism score. SNP S29 also showed significant
correlation with altruism score at the allele level (p=0023; Table
S2). Moreover, the altruism scores showed a propensity to increase
linearly with increasing number of minor alleles present across the
four SNP positions (Figure 2C; p=0.033).
Discussion
The segment flanked by SNPs rs6556547 (S1) and rs187269
(S29) in GABRB2 was earlier shown by us to play important roles
in the etiology of the neuropsychiatric disorders SCZ and BPD
[5,6,10,11]. The positive selection of a number of SNPs in this
segment suggests GABRB2 involvement in not only injurious
mental disease processes, but also the development of traits and
capabilities that benefit human fitness during emergence of the
human lineage. This would be in line with an important role of the
GABRB2 gene in cognitive functions that both underlie SCZ
etiology and are integral to human evolution. The present study
Figure 3. Two-tier grouping of PANSS scores and antipsycho-
tics dosages. (A) PANSS positive scores for Chinese schizophrenics and
(B) average daily antipsychotics dosages for US schizophrenics were
sorted according to the genotypes AA, AG and GG of SNP S3. The
dashed horizontal line in each instance divides the samples into two
groups based on K-Means clustering for PANSS scores, or the clinically-
recommended maintenance antipsychotics dosage of 5 mg/day.
doi:10.1371/journal.pone.0062322.g003
Figure 4. Relative increases in minor allele frequencies in
PANSS score-based SCZ subgroups. Han Chinese SCZ patients
were divided into ‘High’ and ‘Low’ PANSS positive score subgroups
according to the K-Means clustering function. Case-control comparison
was carried out between each patient subgroup and the healthy
control group by means of the LRS test in UNPHASED. Part A: Excesses
in minor allele frequencies in the case cohort over those in the control
cohort are shown for SNPs S1, S3, S5 and S29. Part B: Excesses in
homozygous major (MM), heterozygous (Mm) or homozygous minor
(mm) genotype frequencies in the case cohort over those in the control
cohort are shown for SNPs S1, S3, S5 and S29. In all instances, SCZ
patients with ‘Low’ PANSS score are represented by light blue columns
and SCZ patients with ‘High’ PANSS score by dark blue columns. All
frequency data is given in Table S3 and the statistical data of association
with SCZ is shown in Table 2.
doi:10.1371/journal.pone.0062322.g004
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was accordingly directed to a parallel examination of altruism and
schizophrenic psychosis.
Association of GABRB2 with Psychosis in SCZ
PANSS is a useful measure of psychosis severity in SCZ [34],
and PANSS scores reflecting severity of positive symptoms such as
hallucinations and delusions were found to be significantly
associated with SNPs S1, S3 and S29 in the male Han Chinese
SCZ cohort (p=0.010, 0.010 and 0.041, respectively; Table 1).
These findings were corroborated to some degree by the
association of SNP S5 with average daily antipsychotics dosage
given to SCZ patients in a US cohort (p=0.031; Table 1). The
average daily antipsychotics dosage reflects relative effective dose
within the cohort, and even though effective dosage can be
influenced by other factors including prescribing practice of
psychiatrists and differences in inter-individual drug response, it is
in general indicative of psychosis severity. Therefore, these first
reports of association between GABRB2 and psychosis in SCZ
were cross-corroborated using two different measures of psychosis
in two different ethnic populations. However, it should be noted
that the S29 association with PANSS score and S5 association with
antipsychotics dosage did not pass Bonferroni correction, although
this is mitigated by the test’s tendency for over-correction of
potentially significant results and the presence of supporting
evidence for correlation in the post-hoc results. In addition, the
small sample sizes used reduce the statistical power and so the
actual significance of the findings requires confirmation using
increased sample sizes.
The two-tiered partitioning based on PANSS scores and
antipsychotics dosages allowed a dimorphic subgrouping of SCZ
patients according to psychotic severities. The results in Tables 2,
3, 4 showed that the strength of GABRB2 association significantly
segregated with the patient subgroups having the more severe
psychosis symptoms (for example, p=0.001–0.003 vs. p=0.232–
0.569 for pairwise haplotypes in the patient subgroup with high
PANSS scores vs. subgroup with low PANSS scores), and the
association was due to increased frequencies of minor alleles in
these patient subgroups relative to control (Figures 4 and 5).
Importantly, this finding suggested that the association of GABRB2
with SCZ is centered at the core symptom of psychosis of the
disorder. Similarly, in Figure 6, the expression levels of all four
GABRB2 isoforms in the high antipsychotics dosage SCZ patient
subgroup, but not in the low dosage subgroup, significantly
departed from the controls (p=0.023, 0.047, 0.011 and 0.004 for
the b2S, b2S1, b2S2 and b2L isoforms, respectively), in accord with
the effects of GABRB2 being associated with the psychosis
endophenotype. This association between GABRB2 with psychosis
severity in SCZ is corroborated by parallel observations on other
SCZ-candidate genes including: effects of COMT [20] and DISC
[43] on psychosis severity in SCZ; GABRB2 [26] and COMT [44]
on occurrence of psychosis in BPD; COMT, DAOA and HTR2A on
occurrence of psychosis in Alzheimer’s disease [22,23,45]; and
dopamine dysfunction on occurrence of psychosis in SCZ [46].
Such multi-disease associations with the same psychosis endophe-
notype strongly support the possibility that the involvements of
these genes in psychiatric disorders are mediated at least in part by
Table 3. GABRB2 haplotype association in psychosis severity-based subgroups.
SNP compositiona PANSS score-based groups Antipsychotics dosage-based groups
S1 S3 S5 S29 All High score Low score All High dosage Low dosage
X X 0.007 0.001 0.417 – – –
X X 0.007 0.001 0.320 – – –
X X 0.020 0.002 0.569 – – –
X X 0.008 0.001 0.392 0.515 0.085 0.655
X X 0.018 0.002 0.514 0.256 0.111 0.393
X X 0.007 0.003 0.232 0.194 0.034 0.154
The PANSS score-based groups consist of the full Beijing SCZ cohort (‘All’) and its partitioned ‘High score’ and ‘Low score’ subgroups derived by applying the K-Means
clustering function to the PANSS scores for positive symptoms. The antipsychotics dosage-based groups consist of the full US SCZ cohort (‘All’) and its partitioned ‘High
dosage’ (.5 mg/day) and ‘Low dosage’ (#5 mg/day) groups derived based on the daily standard maintenance antipsychotics dosage of 5 mg fluphenazine equivalent.
The p-values were obtained from case-control association analysis using the likelihood ratio test. Significant p values (p,0.05) that passed the global permutation test
are shown in bold font. aPairwise haplotypes with component SNPs indicated by X.
doi:10.1371/journal.pone.0062322.t003
Table 4. GABRB2 association in antipsychotics dosage-based SCZ subgroups.
All (n = 35) High dosage (n =20) Low dosage (n =15)
Allele Genotype Allele Genotype Allele Genotype
SNP p OR 95% CI p p OR 95% CI p p OR 95% CI p
S3 0.387 1.35 0.68–2.67 0.612 0.087 1.99 0.90–4.38 0.260 0.578 0.77 0.31–1.94 0.122
S5 0.297 1.44 0.73–2.85 0.559 0.034 2.34 1.06–5.19 0.098 0.450 0.70 0.27–1.80 0.222
S29 0.365 1.39 0.68–2.83 0.456 0.222 1.67 0.74–3.78 0.464 0.886 1.07 0.42–2.74 0.192
Based on the average daily antipsychotics dosage of 5 mg fluphenazine equivalent, the US SCZ cohort (‘All’) was divided into ‘High dosage’ (.5 mg/day) and ‘Low
dosage’ (#5 mg/day) groups. The p-values were obtained from case-control association analysis using the likelihood ratio test. Significant p values (p,0.05) that passed
the global permutation test are shown in bold font. The odds ratio (OR) and its 95% confidence level (CI) were based on allele frequencies.
doi:10.1371/journal.pone.0062322.t004
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their contribution to psychosis. In aside, the present findings
implies that sample homogeneity could be increased by consid-
ering psychosis severity, and this can in turn increase the statistical
power of future genetic association studies on SCZ.
Genetic Overlap between the Social Cognition-Related
Phenotypes of Psychosis and Altruism
Altruism refers to behavior that confers a benefit to others at
a cost to oneself, motivated less by self-interest than notions of
fairness and social obligation. Both altruism and psychosis display
significant genetic roots: the heritability of altruism is as high as
0.50 [32] and the heritabilities of the psychotic diseases SCZ and
BPD are well known [47]. Moreover, both altruism and psychosis
are intrinsically linked to social cognition, and a psychosis to
altruism continuum has in fact been employed to furnish
a ‘psychoticism’ measure of individual personality [48]. Therefore,
although hitherto altruism has never been associated explicitly
with either psychiatric disorders or GABAergic function, it cannot
be ruled out that altruism and clinical psychotic behavior share
common genetic elements. In this regard, the SNPs in GABRB2
that are strongly associated with SCZ provide uniquely advanta-
geous genetic probes to search for common genetic elements
between altruism and psychosis. The present study accordingly
examined the possible relationships between altruism and these
SCZ-associated SNPs. The results showed that the minor allele of
S29 relative to the major allele (p=0.023; Table 1, Figure 1C), was
associated significantly with altruistic behavior in healthy Han
Chinese. Although the result did not pass the Bonferroni
correction, the correlation is nevertheless supported by the post-
hoc results. Therefore, GABRB2 plays a significant role not only in
SCZ but also in the genetic predisposition of individuals to
altruism. In particular, the combined minor allele load of the
tested SNPs was predictive for both psychosis (p=0.005; Figure 2A)
and altruism (p=0.033; Figure 2C), highlighting the genetic
overlap as well as the collective importance of these minor alleles
in the two phenotypes. Notably, the Val158Met polymorphism of
the SCZ-associated COMT gene was also found to be associated
with both psychotic symptoms [20,44,45] and altruism [49], with
the major Val allele favoring both increased risk of psychosis and
enhanced inclination for altruism.
Insofar that the social cognitive functions in psychosis and
altruism may be implemented by neuronal gene products of
cognition genes, the possibility arises that GABRB2 of the
GABAergic system and COMT of the dopaminergic system came
to reveal themselves as SCZ-susceptibility genes as well as altruism
genes on account of their putative roles as cognition genes. This
would explain the striking involvement of the same polymorphisms
of GABRB2 and of COMT in both SCZ-psychosis and altruism,
which may be viewed respectively as psychiatric and psychological
manifestations of social cognition.
In conclusion, the present study demonstrated that GABRB2 is
significantly associated with altruism and psychosis in SCZ. Since
the GABRB2-SCZ associations were strong among schizophrenics
with severe psychosis but not schizophrenics with only mild
psychosis based on the PANSS scores, the findings indicated that
the association of GABRB2 with SCZ is centered at the core
symptom of psychosis of the disorder. Furthermore, the associa-
tions of GABRB2 with both psychosis and altruism suggest its
fundamental association with the entire psychiatric to psycholog-
Figure 5. Relative increases in minor allele frequencies in
antipsychotics dosage-based SCZ subgroups. US SCZ patients
were divided into ‘High’ and ‘Low’ antipsychotics dosage subgroups
based on the criterion of 5 mg/day fluphenazine equivalent. Case-
control comparison was carried out between each patient subgroup
and the healthy control group by means of the LRS test in UNPHASED.
Part A: Excesses in minor allele frequencies in the case cohort over
those in the control cohort are shown for SNPs S3, S5 and S29. Part B:
Excesses in homozygous major (MM), heterozygous (Mm) or homozy-
gous minor (mm) genotype frequencies in the case cohort over those in
the control cohort are shown for SNPs S3, S5 and S29. In all instances,
SCZ patients with ‘Low’ antipsychotics dosage are represented by light
blue columns and SCZ patients with ‘High’ antipsychotics dosage by
dark blue columns. All frequency data is given in Table S3 and the
statistical data of association with SCZ is shown in Table 4.
doi:10.1371/journal.pone.0062322.g005
Figure 6. Differential expression of GABRB2 isoforms in
antipsychotics dosage-based SCZ subgroups. US SCZ patients
were divided into a ‘High’ (.5 mg/day) antipsychotics dosage sub-
group (n = 20) and a ‘Low’ (#5 mg/day) subgroup (n = 15). The
expression levels of b2S, b2S1, b2S2 and b2L in the healthy control group
(white), subgroup of patients with ‘Low’ average antipsychotics dosage
(light blue), or subgroup of patients with ‘High’ average antipsychotics
dosage (dark blue) are shown in box-and-whisker representation with
a specified percentile range of 5%–95%. For each isoform, the mean
expression level in the healthy control group was employed to
normalize the data for that isoform. The small square within each box
indicates the mean expression level for that data group. Symbol *
denotes significant difference in expression between the two line-
connected groups.
doi:10.1371/journal.pone.0062322.g006
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ical spectrum of social cognition, thus establishing GABRB2
involvement at the level of social cognition. Given the power of
advances in social cognition in driving the evolution of the human
lineage from its primate roots, GABRB2 as a key genetic element of
social cognition would provide an ample evolutionary rationale for
the strong positive selection observed to be acting on this gene.
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